Clinical Trial Update: Evaluation of Tamoxifen's Efficacy for ER/PR Negative,ER-beta Positive Operable Breast Cancer Patients [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating tamoxifen efficacy in ER/PR-negative, ER-beta positive operable breast cancer patients is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Tamoxifen (tamoxifen)

Snippet

Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | Conditions: Breast Cancer | Phase 3 | Status: RECRUITING